BioPhorum, a global forum for biopharmaceutical industry collaboration, has formed a new working group aimed at accelerating innovation across small molecule manufacturing. 1 The Synthetic Molecule ...
Expanded facility integrates Syngoi Technologies’ enzymatic DNA platform into Artis’ North American operations, ensuring resilient, U.S.-based, clinical-grade supply chains for advanced therapies ...
TOKYO, Jan 27 (Reuters) - A plan to build a synthetic diamond plant in the United States is a prime prospect in Japan's $550-billion investment package, as the allies push to expand production of a ...